RPS15AP7

Across TCGA pan-cancer cohorts, RPS15AP7 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RPS15AP7 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RPS15AP7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS15AP7 expression acts as an unfavorable survival marker, although some lineages such as HNSC and STAD show a favorable association.

MESO, HNSC, and DLBC are the cancer types where RPS15AP7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.123	0.564	<.001	126	view →
HNSC	OS	Tertile	III,IV	0.835	0.299	.006	75	view →
DLBC	OS	Tertile	III,IV	0.154	0.735	.010	52	view →
SARC	DFS	Tertile	All	0.160	0.602	.001	30	view →
UCEC	DFS	Tertile	IV	0.206	0.704	.033	18	view →
LUAD	DFS	Tertile	IV	0.285	0.724	.022	18	view →
STAD	OS	Median	IV	0.563	0.193	.016	15	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RPS15AP7–MESO (OS)

Open the MESO breakdown →